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Introduction
Thyroid cysts are common in humans as well as 
in animals [1]. Hemorrhagic thyroid cysts were
recorded in 1950 in MEDLINE [2]. Otherwise, thy-
roid cysts remain a loosely defined term for thyroid
disease. Before the widespread application of ultra-
sonography, a cyst was defined as any fluid-filled
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Thyroid ultrasonography has been used to detect thyroid lesions since the 1960s. In early
1970s, thyroid cyst had been reported to present as thyroid nodules. With over one-third of all
isolated thyroid nodules being cystic, over half exhibit cystic degeneration and approximately
17–32% of the cystic thyroid nodules are malignant. The pathogenesis of thyroid cysts is
unknown. Possible causes include infarcts and other destructive processes including hem-
orrhaging in the thyroid follicle, clustering of thyroid follicles followed by cystic degeneration,
and benign or malignant tumor necrosis. Cystic fluid analysis for amylase, lactate dehydroge-
nase and acid phosphatase reveals substantially higher levels than in the serum. Immuno-
reactive endothelin, vascular epithelial growth factor and β2-microglobulin were investigated
in the cystic fluid of developing and recurrent thyroid nodules. Ultrasound-guided aspiration
near the solid part of the thyroid cysts, combined with cytologic study by experienced
endocrine cytopathologists, constitutes the best form of preoperative diagnosis of malignant
thyroid cysts. Of the malignant cysts, most are papillary thyroid carcinoma. However,
medullary cystic carcinoma and anaplastic thyroid carcinoma with cystic changes are also
reported. Observation, repeated aspiration, thyroid hormone therapy, percutaneous ethanol
injection, ultrasound-guided interstitial laser photocoagulation and surgical treatment are
the most common treatment for thyroid cysts. Depending on the definition of response
rate and the period of follow-up, the response rate to ethanol injection for thyroid cysts
ranges from 72.1% to 93.9%. In conclusion, the pathogenesis of the thyroid cysts requires
further investigation. Recurrent thyroid cysts larger than 3cm may require surgical treatment.
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cavity exceeding 1 cm in diameter or aspirated cys-
tic fluid over 2 mL [3,4]. Because most thyroid cysts
are benign lesions, they do not normally receive
surgical treatment. The incidence of thyroid can-
cer in thyroid cysts and cystic degeneration of thy-
roid cysts is difficult to determine. Depending on
how a thyroid cyst is defined, over one-third of all
isolated thyroid nodules are cysts [5]. Fine needle
aspiration cytology (FNAC) is conventionally used
to distinguish benign from malignant thyroid nod-
ules. The diagnostic accuracy of thyroid ultraso-
nography with FNAC of solid thyroid nodules is
widely recognized by clinicians. In cystic changes
of the thyroid masses, the accuracy is less clear
[6,7].
Clinical Features
Most thyroid cysts are benign thyroid lesions.
However, a few of the thyroid cysts present as 
simple cysts (Fig. 1). Most thyroid cysts present
with nodular goiter with cystic change or thyroid
cysts with septum (Figs. 2 and 3). Anatomic terms,
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Fig. 1. Ultrasonography of a simple cyst in the right thyroid of a 45-year-old male presenting with smooth wall. (Real-time mode
with a 10 MHz transducer)
T
Fig. 2. Thyroid ultrasonography of 32 female patients presenting with right thyroid nodule and multiple cystic degeneration.
such as mixed lesion or complex lesion, are used
sometimes in thyroid ultrasonographic examination.
Before the widespread use of thyroid ultrasonog-
raphy, differentiating simple cysts from the other
complex lesions was difficult. Improvements in ultra-
sonographic technology and imaging resolution
currently allow the identification of cysts less than
5 mm in size. A recent retrospective study reviewed
ultrasonographic data of 6,219 patients with thy-
roid nodules treated in a single medical center [8].
The data revealed 1,983 cystic changes and 4,236
solid masses. Following FNAC examination, 506
(11.9%) patients with solid masses underwent sur-
gical treatment, in comparison with 143 with cys-
tic changes in thyroid masses (7.2%). Of the 649
nodules treated surgically, 29.8% (151/506) and
9.1% (13/143) were malignant in the solid and
cystic change groups, respectively. Overall, after sur-
gical treatment, 0.65% of cystic changes in thyroid
lesions were diagnosed as thyroid cancer. Diag-
nostic accuracy of FNAC in cystic changes of the
thyroid masses after ultrasonographic examination
was comparable to that for solid thyroid nodules.
Determining the precise incidence of malignancy in
thyroid cystic changes is difficult, because prospec-
tive studies of surgical treatment for all thyroid cys-
tic changes are not possible. A specific sonographic
sign, with multiple punctate echogenic foci suggest-
ing calcification in solid excrescences protruding
into the cysts, has been identified as specific to cystic
change of papillary thyroid carcinoma [9]. Diagnostic
accuracy of FNAC in cystic change of thyroid malig-
nancies is usually lower than that in solid masses,
with sensitivity and specificity of 88% and 52%,
respectively, for cystic change in papillary thyroid
carcinoma reported in one study [10]. Diagnostic
accuracy depends on the case and diagnostic pro-
cedure employed.
Surgery has previously been recommended for
patients with thyroid cystic changes exceeding 3cm,
those with persistent growth or if repeated aspi-
ration does not yield adequate cells for interpreta-
tion of FNAC [11]. To improve diagnostic accuracy,
ultrasound-guided FNAC and cytologic criteria for
cystic change in papillary carcinoma have been used
[12–14]. Atypical cells or indeterminate cells revealed
by FNAC, indicating thyroid cystic changes later
shown to be malignant, may exhibit cohesive flat
sheets, distinct cell borders, nuclear enlargement,
nuclear grooves, dense granular cytoplasma, small
distinct nucleoli, fine chromatin, and elongated or
spindled cytomorphology [15]. No specific features
of cytomorphology are characteristic of cystic change
of thyroid cancer unless aspirated from the solid
portion of mixed thyroid nodules. As in previous
investigations, the incidence of pre-operatively diag-
nosed carcinoma was low in thyroid cystic changes
after FNAC [16]. Inconclusive results of FNAC for
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Fig. 3. Right thyroid cyst in 42 female patients with septum in the cyst.
thyroid cystic changes are common because of the
difficulty in obtaining adequate cells [7,17]. Although
repeat aspiration or centrifugation of the aspirates
may yield improved results [11], accurate diagno-
sis of larger cystic changes (e.g. > 3 cm) remains
problematic.
Pathologic and Biochemical
Characteristics of Thyroid Cysts
The content and composition of thyroid cysts 
may vary. Contents may include thick colloids, a
gelatinous substance, hemorrhagic brownish fluid,
chocolate-colored fluid or clear yellowish fluid. Cystic
thyroid disorders may result from clear fluid cysts,
thick colloid cysts, cystic echinococcosis [18], hydatic
cysts [19], intrathyroidal thyroglossal ducts cyst
[20], lymphoepithelial cysts [21], epithelial cysts,
epidermoid cysts [22,23], thyroid abscess [24] or
various thyroid cancers [25–27]. Histopathologic
findings for thyroid cysts may reveal simple cysts,
colloid degeneration, colloid adenoma, follicular
adenoma, malignancy or thyroiditis. Although the
nature of cystic transformation in thyroid cancer is
unknown, different histopathologic patterns of thy-
roid carcinoma have been documented. Diagnostic
pitfalls may be present in both papillary thyroid
carcinoma with cystic change in primary tumor site
and in metastatic lymph nodes and the follicular
neoplasm [28]. Figure 4 presents the histopatho-
logic features of different benign and malignant
cysts. Most malignant thyroid cysts are papillary
thyroid carcinoma (Fig. 4C). Histologically, thyroid
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Fig. 4. Histologic examination of a thyroid cyst may show (A) simple thyroid cyst lined by a single layer of follicular cells, (B) thy-
roid cyst with papillary hyperplasia, (C) papillary thyroid carcinoma with cystic degeneration, or (D) follicular thyroid carcinoma
with cystic degeneration. Adapted from Lin et al [8].
cysts may be the result of cystic degeneration of
nodular goiter, follicular adenoma, papillary carci-
noma or follicular carcinoma.
Surgically proven benign and malignant cystic
fluids contain the thyroid hormones thyroxine and
triiodothyronine, thyroglobulin, and thyroxine-
binding globulin. None of these assays could dis-
tinguish benignity from malignancy. Biochemical
analysis of amylase, lactate dehydrogenase and acid
phosphatase showed much higher levels in the
cystic fluids than in the serum. The elevated activ-
ity of these enzymes was considered to be thyroidal
in origin [29]. Increased aspartate aminotransferase,
lactate dehydrogenase activity, and high concen-
tration of total protein, uric acid, iron and total
bilirubin indicated red blood cell sources with recent
and previous hemorrhages. Concentrations of glu-
cose, cholesterol and triglyceride in the cyst fluid
were within the normal serum range [29]. The
gross appearance of the fluid, together with the
presence of biochemical substances, suggested a
hemorrhagic origin for most cysts. Other possibili-
ties were autolysis or necrosis of thyroid tissue and
inflammation.
Pathogenesis
In earlier studies, the structure and motility of pri-
mary cilia in the follicular epithelium of the human
thyroid has been demonstrated in normal, benign
and malignant thyroid tissues [30–32]. Histologic
observation has disclosed two epithelial cells:
columnar epithelium with mucous content or with
cilia, and squamous epithelium with or without ker-
atinization [33]. The presence of cilia may be used
as a marker for differentiating thyroid follicular
cells. Immunohistochemical profiles of epithelial
cells are used to characterize cyst origins in organs
such as liver or spleen [34–37].
The cyst may emerge from infarcts or other
destructive processes such as hemorrhage in pre-
existing follicles or cavities [32]. Three-dimensional
comparison of the colloid goiter or preexisting ade-
noma had revealed that large vessels are mainly 
located at the nodule periphery while the parench-
yma contains only rare thin vessels [38]. Infarction
may occur after continuous growth of the thyroid
nodules. The mechanism whereby expanding thy-
roid follicles become enlarged over 100 times (from
50 µm to 0.5 cm for instance) as a thyroid cyst is
unknown. Any insult causing subepithelial inflam-
matory process or hemorrhage of the thyroid folli-
cle may elevate the pressure of perifollicular space.
The increased pressure may affect microcirculation
in the subepithelial area.
Thyroid cysts with multiple septa are not
unusual (Fig. 3). Following aspiration in the deep-
est portion of the cyst, more fluid appears upon
withdrawal of the needle to the superficial portion.
The origin of these “cysts within a cyst” is difficult
to determine by tumor necrosis or septa growth
from the wall of the cyst. A possible mechanism is
clustering of the thyroid follicles followed by cystic
degeneration. In both benign and malignant thyroid
tumors, the balance between cell proliferation and
cell death is important to maintain tissue homeo-
stasis. Apoptosis and cell necrosis are major pro-
cesses in thyroid epithelial cell death. In contrast 
to normal cells, the majority of goiter cells do not
respond to TRAIL- or Fas-mediated apoptosis by
cytokine pretreatment [39]. Necrosis is due to a
relatively insufficient blood supply which cannot
sustain the growth of replicating neoplasia [40,41].
Vessel distribution in benign and malignant thy-
roid lesions has been studied with histologic stere-
omicroscopic three-dimensional reconstruction [38].
Poorly differentiated follicular thyroid carcinoma
and medullary carcinoma contain large intratumoral
vessels surrounding avascular areas corresponding
to solid neoplastic cellular sheets with necrosis.
Papillary thyroid carcinomas are more vascularized
and contain numerous vascular anastomoses. Further
information is needed concerning cytokines, growth
factors as vascular endothelial growth factor (VEGF),
immunoreactive endothelin [42], β2-microglobulin
[43] or any tumor marker in the cystic fluid which
could distinguish benign from malignant cysts [44].
Differences in pathogenesis between benign and
malignant thyroid cysts need further investigation.
Ultrasonography in Thyroid Cysts
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Ultrasound Diagnosis and Differential
Diagnosis
Ultrasonographic and pathologic correlations repor-
ted from Japan revealed that 17% of thyroid cysts
were malignant [45]. Of the various sonographic
findings of cystic thyroid masses, oval cystic lesions,
with a polyp or dome-like solid component project-
ing into the lumen, were all identified as adeno-
matous goiter (Fig. 5). Uneven cystic structures, with
finger-like pedunculated mass of more than 2 cm
thrust into and/or out of lumen, were all diagnosed
as papillary carcinoma. Small oval cysts (≤ 1 cm)
with strong echo were all confirmed as colloid goi-
ter. Size of the thyroid cyst should not be regarded
as differentiating benignity from malignancy. Timing
of the ultrasonographic examination during tumor
growth is important. When thyroid ultrasonography
is used after detection of thyroid nodule by physi-
cal examination, most tumors prove to be larger
than 1 cm. Thyroid cysts may demonstrate coexis-
tence with thyroid microcarcinoma in the thyroid
cystic wall. These thyroid papillary microcarcinomas
in the thyroid cysts were mostly incidental findings
in the final histopathology after surgery.
Differential diagnosis should be considered for
thyroglossal duct cyst and parathyroid cyst. The
thyroglossal duct forms during descent of the thy-
roid from the foramen cecum at the base of the
tongue and normally disappears during the sixth or
seventh gestational week. One percent of thyroid
cancer evolves from the thyroglossal duct cyst, and
1.5% of thyroglossal duct cysts have been diagnosed
with well-differentiated thyroid carcinoma [46,47].
This carcinoma has often been diagnosed inciden-
tally after surgical excision. Like thyroid cysts, benign
thyroglossal duct cyst presents with an anechoic pat-
tern at ultrasonographies, whereas cysts contain-
ing carcinoma and adenoma show a mural nodule
[48]. In a previous study, FNAC proved to be the
best and cheapest method of diagnosis for thyroid
cancer in thyroglossal duct cyst [49]. Results for
surgical procedures and follow-up of thyroglossal
duct with cancer are usually comparable for well-
differentiated thyroid cancer. The Sistrunk operation
is adequate for most patients with incidentally diag-
nosed thyroglossal duct cysts, in the presence of
clinically and radiologically normal thyroid gland.
The 5- and 10-year Kaplan–Meier survival rates were
100 and 95.6%, respectively [50].
Parathyroid cystic lesions account for an esti-
mated 1–5% of neck cysts [51]. They may present
as neck swellings that may be mistaken both clini-
cally and cytologically as thyroid nodules [52]. Patho-
logically, parathyroid lesions may include simple
cysts, hyperplasia, adenoma or carcinoma [51,53,
54]. In contrast to thyroid cysts, most parathyroid
cysts were aspirated as clear, colorless or watery fluid.
Extremely high levels of calcium and C-terminal
mid-molecule parathyroid hormone assay could be
detected. Although intracystic parathormone meas-
urement is important for diagnosis, only two cases
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Fig. 5. Polyp or dome-like solid component projecting into the lumen of the right thyroid cyst. A = artery; C = cyst; T = trachea.
out of the 10 parathyroid cysts were measured in
one study [55]. Differential diagnosis of thyroid cysts
with parathyroid, preoperatively, is important. Most
parathyroid enlargements presenting in ultrasono-
graphies are hypoechoic to anechoic lesions. When
ultrasonography reveals cystic lesions near the post-
erior thyroid capsule, parathyroid cyst or enlarge-
ment should be listed as the differential diagnosis.
Therapy for Thyroid Cyst
Application of thyroid ultrasonography changes the
therapeutic modality for thyroid cyst. Most thyroid
cysts were previously diagnosed and treated with
surgery. In addition to ultrasonography, observation,
repeat aspiration [56–58], thyroid hormone therapy
[56,59] and sclerotherapy [4,60–62], laser photoco-
agulation [63] and surgical treatment [7] are the
main methods for treating thyroid cysts. Because
of the benign clinical course of most thyroid cysts,
few investigations have reported prospective long-
term follow-up for benign thyroid cyst. One recent
study of 1-month to 5-year follow-up examinations
revealed that nodules with greater cystic content
were less likely to grow, compared with solid nod-
ules [64]. The estimated proportion of nodules with
a 15% or greater increase in volume after 5 years
was 89%. Prior to determining non-surgical treat-
ment for thyroid cysts, definite diagnosis as benign
lesion is crucial.
A study of instillation of intracystic tetracycline
hydrochloride treatment was conducted in nine pa-
tients following repeat cyst aspiration [65]. After a
mean of 40 months of follow-up, all except two of
the cysts were completely resolved. Follow-up studies
revealed a 43–95% response rate for the tetracyc-
line treatment [66–68]. A randomized double-blind
study was performed in 66 consecutive recurrent
and benign patients. A recent study compared eth-
anol instillation with isotonic saline and subsequent
complete emptying for treating recurrent thyroid
cysts [4]. An 18–64% rate of cure was observed in
both groups. Efficacy of percutaneous ethanol injec-
tion for treating thyroid cysts versus solid thyroid
nodules has proven superior in cysts. Volume reduc-
tions of 65–38.3% (p < 0.01) were observed in both
groups [60]. In contrast to tetracycline sclerotherapy,
hydrochloric acid (pH 1.0) has been used to treat
thyroid cysts [61]. Hydrochloric acid demonstrates
no advantage over ethanol injection. A prospective,
large series study of 98 symptomatic thyroid cystic
nodules explored the long-term efficacy of percuta-
neous ethanol injection over a follow-up of 9 years.
In 92 of 98 patients with more than 50% nodule
shrinkage, only six of the 92 respondents relapsed.
In summary, ethanol injection is an effective, inex-
pensive procedure with high patient compliance
and long-term effects in treating cysts larger than
40mL [61]. Depending on the definition of response
rate and period of follow-up, the response rates of
ethanol injection for thyroid cyst range from 72.1%
to 93.9% [4,62,69,70].
Thyroid cysts are often surgically removed to
minimize malignancy and recurrence after repeat
aspiration [71]. Approximately 55% of cystic papil-
lary thyroid carcinoma revealed false-negative results
in a retrospective study [25]. Recurrence after two
aspirations of cystic fluid, together with suspected
malignancy in aspiration cytology or in cysts larger
than 3 cm, are considered indications for surgical
removal of the cysts [63,72]. Figure 6 lists recom-
mended diagnosis and therapy for thyroid cysts or
Ultrasonography in Thyroid Cysts
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Thyroid cyst
Ultrasound and aspiration
Benign or fluid*
Follow-up 3 mo
Benign
(< 3 cm)
Benign
(≥ 3 cm)
Malignant
or suspicious
Sclerotherapy
Malignant
or suspicious
Surgery
Echo-guided aspiration
Surgery
Follow-up
6 mo later
Fig. 6. Flowchart for diagnosis and recommended therapy for
thyroid cysts. *Aspiration from solid portion if possible.
cystic degeneration of thyroid nodules. Percuta-
neous ethanol injection is the recommended treat-
ment for cystic thyroid lesions by the American
Association of Clinical Endocrinologists [73]. Sclero-
therapy is not the routine therapeutic modality 
in most Taiwan hospitals. Furthermore, this more
“invasive therapy” carries risks of complications;
most of these cases receive follow-up ultrasonog-
raphy and repeat FNAC for 6–12 months. Enlarged
cysts after repeated aspirations are an indication
for surgical treatment (Fig. 7).
Prospective studies of surgical treatment for all
thyroid cysts are not possible. Definitions of thyroid
cysts vary considerably. Although other histologic
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Fig. 7. A 39-year-old female presented with bilateral thyroid nodules. (A) Ultrasonography of thyroid nodules. Right thyroid (A1)
with cyst and left thyroid (A2) with isoechoic solid mass with complete “halo” sign. (B) Liu’s stain of fine needle aspiration cytology
from bilateral thyroid nodules. Surgically proved this case with right nodular hyperplasia with cystic degeneration and left follicular
variant of papillary thyroid carcinoma.
types of thyroid cancer with cyst have been docu-
mented [74,75], papillary thyroid carcinoma has
proven to be the most common histologic type.
Further study is needed to clarify the actual inci-
dence of cysts in different thyroid cancers. Patho-
physiology of cystic changes in different thyroid
cancers also requires further investigation. Diag-
nostic accuracy of FNAC in these cystic thyroid
malignancies is usually lower than in solid masses.
Sensitivity and specificity of 88% and 52%, respec-
tively, to cystic papillary thyroid carcinoma was
observed in one study [10]. Detailed classification
of thyroid cysts in seven categories has been re-
ported [76]. Eighty percent of malignancies involve
larger cysts with projections exceeding 1 cm and
unevenly mixed cystic and solid components. A
specific sonographic finding of multiple punctate
echogenic foci, suggesting calcification in solid ex-
crescences protruding into the cyst, has been specif-
ically identified as cystic papillary thyroid carcinoma
[9]. Cystic degeneration of the metastatic lymph
node of the papillary thyroid carcinoma is com-
monly observed [28,77,78], although the primary
tumor may appear as a solid mass in the thyroid.
Comparison of patient demographics, including age,
gender, tumor size, and prognosis of the cystic and
solid thyroid cancers demonstrate no statistical 
difference [9].
Conclusion
Pathogenesis of thyroid cysts in benign and malig-
nant nodules requires further investigation. The VEGF
level, galectin-3 or comparison of 53P, telomerase
activity in aspirate from the cysts may serve as differ-
entiation markers between benign and malignant
cysts. In conclusion, more data are needed to clar-
ify the role of growth factors or oncogenes in the
growth and malignant transformation of these
lesions. Sclerosing therapy is effective in compres-
sive and cosmetic symptoms for most benign cysts.
However, ultrasonographic guided FNAC with care-
ful cytologic interpretation is crucial to avert misdiag-
nosing malignant cysts.
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